SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
The Audit Committee dismissed PricewaterhouseCoopers AB (PwC Sweden) as the independent registered public accounting firm and appointed PricewaterhouseCoopers LLP, United States (PwC US) as the new auditor effective immediately after the Distribution, reflecting the company's transition to independent public company status.
View raw filing on EDGAR →The Compensation Committee approved two compensatory arrangements on May 20, 2026: (1) one-time transaction bonuses totaling $2.85 million for named executive officers (Mattias Stenberg $950,000, Benjamin Maslen $800,000, Anthony Zana $800,000, Scott Moore $300,000) with repayment conditions tied to voluntary termination within one year; and (2) adoption of the Octave Intelligence plc Executive Annual Incentive Plan effective January 1, 2026, establishing a framework for annual cash incentive awards based on performance goals.
View raw filing on EDGAR →Strive announced a significant bitcoin purchase of 1,109 BTC at ~$76,989 per coin during May 19-22, 2026, along with material changes to its balance sheet composition (cash, bitcoin holdings, and equity issuances). The company also disclosed plans to refresh its ATM programs. While this reflects treasury management and asset allocation decisions rather than a discrete event type (M&A, litigation, restatement, etc.), the scale of the bitcoin acquisition and the resulting changes to shareholder equity structure would materially affect a reasonable investor's assessment of the company's financial position and strategy.
View raw filing on EDGAR →Paul R. Hibbert departed as Chief Supply Chain Officer effective June 1, 2026. The disclosure notes his severance eligibility under the Executive Severance Plan.
View raw filing on EDGAR →Anthony Freve was appointed as Chief Supply Chain Officer effective June 1, 2026, succeeding Paul R. Hibbert in this key operational leadership role.
View raw filing on EDGAR →Senti Biosciences issued $10.0 million in Senior Secured Convertible Notes to Celadon Partners SPV 24 on May 20, 2026, pursuant to a Securities Purchase Agreement. The convertible notes are dilutive securities that can convert to equity, materially affecting shareholder equity and voting power.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Mondelez's May 20, 2026 annual meeting of shareholders under Item 5.07. The filing presents detailed voting tallies for five matters: election of 10 directors, advisory approval of named executive officer compensation, ratification of PricewaterhouseCoopers LLP as independent auditors, and two shareholder proposals (both rejected). The disclosure of director elections and auditor ratification are material governance events that affect investor understanding of board composition and audit oversight.
View raw filing on EDGAR →Zebra Technologies held its Annual Meeting of Stockholders on May 19, 2026, with voting results on four proposals: election of four Class III directors, advisory vote on named executive officer compensation, approval of the 2026 Long-Term Incentive Plan, and ratification of Ernst & Young LLP as independent auditors.
View raw filing on EDGAR →Digital Turbine issued a press release on May 26, 2026 announcing financial results for the quarter ended March 31, 2026, with the announcement attached as Exhibit 99.1. This is a standard quarterly earnings disclosure under Item 2.02, which is the designated Item for results of operations and financial condition. The filing explicitly references the press release and forward-looking statements typical of earnings announcements.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Finward Bancorp's Annual Meeting of Shareholders held on May 22, 2026, filed under Item 5.07. The filing presents detailed voting outcomes for three proposals: election of three directors (Benjamin J. Bochnowski, Robert E. Johnson III, and Martin P. Alwin to three-year terms), ratification of Forvis Mazars, LLP as independent auditor, and an advisory vote on executive compensation. All three proposals passed with substantial majorities. This is a routine but material disclosure required by Item 5.07 of Form 8-K.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting of Shareholders held on May 26, 2026. The filing reports voting outcomes for two proposals: (i) reelection of two Class II directors (Brian Sedrish and James Fagan) and (ii) ratification of CohnReznick LLP as independent auditor. Both proposals passed with substantial majorities. This is a quintessential Item 5.07 disclosure and is material to investors as it confirms board composition and auditor appointment.
View raw filing on EDGAR →Christopher P. Litterio, who held three senior roles (General Counsel, Secretary, and Senior Vice President of Human Resources), informed the company on May 19, 2026 of his plan to retire. The disclosure centers on the departure of a named executive officer from multiple material positions, making this an executive departure event. The retirement of a General Counsel and senior HR executive is material to investors as it affects corporate governance and organizational leadership.
View raw filing on EDGAR →Nicholas Johnson was appointed as Chief Executive Officer of Medifast Inc., effective June 1, 2026, succeeding Daniel R. Chard who transitions to non-executive Chairman. The appointment was approved by the Board on May 20, 2026, and disclosed via press release.
View raw filing on EDGAR →At the Annual Meeting of stockholders, four proposals were submitted to a vote and all passed with substantial majorities: (i) election of seven directors to the Board, (ii) ratification of RSM US LLP as independent auditor, (iii) advisory vote on named executive officer compensation, and (iv) approval of the Amended 2012 Plan.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from Ardent Health's Annual Meeting of Stockholders held on May 20, 2026. The filing reports voting outcomes on three matters: election of 11 directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. All three votes passed with substantial majorities, making this a material disclosure of governance outcomes that investors rely upon to assess board composition and executive accountability.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the May 22, 2026 Annual Meeting of Stockholders, with detailed voting tallies for five proposals including director elections, auditor ratification, executive compensation approval, and stock plan amendments. Item 5.07 explicitly requires disclosure of shareholder voting results, and the material outcomes (all proposals approved) affect investor understanding of governance and capital allocation decisions.
View raw filing on EDGAR →Lincoln International entered into material definitive agreements in connection with its initial public offering on May 19, 2026, including the Fourth Amended and Restated Limited Partnership Agreement, Tax Receivable Agreement, and Voting Agreement, constituting a material change of control event affecting the company's ownership and governance structure.
View raw filing on EDGAR →Lincoln International completed an initial public offering of 24,207,486 shares of Class A common stock at $20.00 per share, generating gross proceeds of $473.7 million, and issued approximately 81 million shares of Class B and Class C common stock to existing and controlling partners under Section 4(a)(2) exemption, materially diluting existing shareholders.
View raw filing on EDGAR →The company appointed two new directors, M. Christie Smith and John W. Oleniczak, effective May 19, 2026, with specified committee assignments, and disclosed employment agreements with the CEO and President.
View raw filing on EDGAR →The company disclosed a material modification to rights of security holders, with the substance incorporated by reference from Item 5.03, relating to governance or capital structure changes affecting security holder rights.
View raw filing on EDGAR →Precision BioSciences held its annual meeting of stockholders on May 21, 2026, with shareholders voting on six proposals including director elections (Melinda Brown and Geno Germano), auditor ratification (Deloitte & Touche LLP), executive compensation approval, and amendments to the 2019 Incentive Award Plan and Certificate of Incorporation. All proposals were approved by shareholders.
View raw filing on EDGAR →Peloton appointed Siddharth Thacker as Chief Financial Officer effective June 22, 2026, replacing interim CFO Saqib Baig. The appointment includes a base salary of $635,000, bonus eligibility, and $8,000,000 in equity awards.
View raw filing on EDGAR →This Item 2.03 disclosure describes the creation of direct financial obligations through the issuance of consolidated obligations (bonds and discount notes) by the Federal Home Loan Bank of New York. While the filing explicitly states "consolidated obligations issuance is material to the Bank," the disclosure is primarily informational and regulatory in nature—explaining the structure, joint and several liability framework, and reporting methodology for consolidated obligations rather than announcing a specific new debt issuance event. The absence of a Schedule A with specific issuance details and the emphasis on general policies and disclaimers suggest this is a routine periodic disclosure of the Bank's debt issuance program rather than a discrete material event triggering Item 2.03.
View raw filing on EDGAR →The filing discloses results of the Company's 2026 annual meeting of stockholders held on May 22, 2026. Although no votes were formally cast due to lack of quorum (only 219.7M of 722.2M shares represented), the Company received and reports proxy voting instructions on director elections, executive compensation advisory votes, auditor ratification, and compensation frequency—the standard matters voted at annual meetings. The disclosure of proxy voting patterns, even absent a quorum, constitutes shareholder vote results material to investors regarding governance and director continuity.
View raw filing on EDGAR →The filing discloses two significant Board-approved actions: (1) launch of a digital asset treasury 2.0 program involving cryptocurrency trading and a Coinbase account, and (2) assignment to the Company of up to $10 million from a $57.9 million judgment awarded to CEO Vikram Grover against NSAV et al., with consideration to be paid in Company Notes, Preferred Stock, or Common Shares. While the judgment assignment could signal potential dilutive issuance or material litigation settlement, the disclosure centers on Board approval of strategic initiatives and a contingent asset acquisition rather than a completed transaction or traditional event type. The cryptocurrency treasury program and judgment monetization represent material strategic decisions affecting shareholder value, but do not fit cleanly into the standard taxonomy categories.
View raw filing on EDGAR →DuPont held its Annual Meeting of Stockholders on May 21, 2026, with shareholders voting on four agenda items: election of 10 directors, advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as auditor, and approval of a reverse stock split amendment. The reverse stock split approval is particularly material as it represents a significant corporate action requiring stockholder authorization.
View raw filing on EDGAR →The Board of Directors approved a 1-for-3 reverse stock split effective June 24, 2026, which directly affects share count and per-share metrics for all shareholders.
View raw filing on EDGAR →Lamb Weston's wholly owned subsidiary LW Ulanqab entered into a material definitive facility agreement on May 19, 2026, providing a RMB 700 million (approximately USD 102.9 million) term loan facility with a five-year maturity. This material debt financing transaction affects the registrant's financial position and obligations.
View raw filing on EDGAR →Amendment No. 12 to a promissory note with LGH Investments, LLC extended the maturity date to September 30, 2026. The amendment to this debt obligation may signal refinancing pressure or financial stress, though it does not constitute a covenant breach or other terminal event.
View raw filing on EDGAR →Nocera entered into an Equity Purchase Facility Agreement on May 22, 2026, granting an institutional investor the right to purchase up to $100 million in newly issued common stock over a 24 months, issued in reliance on Section 4(a)(2) of the Securities Act. The transaction is subject to a 19.99% Exchange Cap absent stockholder approval and represents a material capital-raising transaction that will significantly affect shareholder equity and voting power.
View raw filing on EDGAR →The filing discloses multiple capital transactions (Series B preferred conversion, redemption, and a $4M warrant offering with Armistice) undertaken to restore compliance with Nasdaq's $2.5M stockholders' equity listing requirement. While these transactions involve dilutive issuances and equity restructuring, the core disclosure centers on the company's efforts to maintain continued listing status and its assertion of current compliance with Nasdaq standards—a material governance and going-concern-adjacent matter that does not fit neatly into the dilutive_issuance category alone, as the primary event is the restoration of listing compliance rather than the issuance itself.
View raw filing on EDGAR →Zscaler issued a press release on May 26, 2026 announcing financial results for the third fiscal quarter ended April 30, 2026, with the press release furnished as Exhibit 99.1. This is a standard quarterly earnings disclosure under Item 2.02, which is material to investors as it provides the company's periodic financial performance and results of operations.
View raw filing on EDGAR →The Company entered into a deed of waiver with Baker Bros. Advisors LP restricting the Shareholders' ability to convert Class A1/B1 shares into Class A/B shares if doing so would result in beneficial ownership exceeding 49.9% of voting rights. While this is a material definitive agreement affecting shareholder rights and voting control, it does not fit cleanly into the M&A activity category (no acquisition, disposition, merger, or change of control is occurring) and is better classified as a structural governance arrangement that would affect investor assessment of control and dilution risk.
View raw filing on EDGAR →Rhinebeck Bancorp announced a public offering of 8,912,500 shares at $10.00 per share in connection with conversion from a mutual holding company to a fully stock holding company. This is a material dilutive equity issuance that would significantly affect shareholder ownership and the company's capital structure, warranting disclosure under Item 8.01.
View raw filing on EDGAR →Blue Owl Credit Income Corp. completed an unregistered private placement of 117,762 shares of Class I common stock to feeder vehicles on May 1, 2026, for approximately $1.08 million, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →The company declared monthly distributions to shareholders across three share classes, reported the status of its continuous and private offerings, disclosed May 2026 public offering prices and NAV per share, and provided portfolio and leverage metrics as of April 30, 2026.
View raw filing on EDGAR →The Board approved a $25 million share repurchase program, which is a material capital allocation decision that affects shareholder value and the company's financial position. While share repurchases are common corporate actions, a $25 million authorization is material to a reasonable investor's assessment of the company's capital strategy and financial health. This does not fit neatly into the more specific event categories (it is not a dilutive issuance, M&A activity, or executive compensation), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Aurora Innovation's May 21, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: election of three Class II directors (Gloria Boyland, Michelangelo Volpi, and Lara Caimi), advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditor. The disclosure includes vote counts (For, Against, Abstain, Broker Non-Votes) for each proposal, which is the hallmark of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from TaskUs's 2026 Annual Meeting of Stockholders held on May 21, 2026. The filing reports the final voting outcomes for two proposals: (1) election of three Class II directors (Jaspar Weir, Michelle Gonzalez, and Amit Dalmia), and (2) ratification of KPMG LLP as the independent registered public accounting firm. The disclosure includes vote counts (For, Against/Withheld, Abstain, and Broker Non-Votes) for each proposal, which is the standard format for Item 5.07 shareholder vote results disclosures. Director elections and auditor ratifications are material governance matters affecting investor assessment of the company's leadership and financial oversight.
View raw filing on EDGAR →The filing discloses a delisting notice and subsequent cure. The Company received a November 2025 notice from Nasdaq that it failed to comply with Listing Rule 5550(b) minimum standards (stockholders' equity, market value, or net income), but on May 20, 2026, Nasdaq notified the Company that it has returned to compliance with continued listing requirements. This is a material delisting-risk event that directly affects the registrant's ability to maintain its listing status.
View raw filing on EDGAR →Nuvve received written notice from Nasdaq on May 22, 2026, that it failed to comply with Listing Rule 5250(c)(1) by not filing its Form 10-Q for the period ended March 31, 2026. This notice serves as an additional basis for delisting, compounding the Company's existing delisting risk from its stock price falling below $1.00 per share for 30 consecutive trading days, and the Company is currently before the Nasdaq Hearings Panel.
View raw filing on EDGAR →Core Scientific appointed Steve M. Smith to its Board of Directors and Nominating and Corporate Governance Committee, effective May 26, 2026. Smith brings significant experience as former CEO of Equinix and Zayo and as a board member of NextDC, and was determined to be independent.
View raw filing on EDGAR →APA Corp held its Annual Meeting of Shareholders on May 26, 2026, with shareholders voting on four proposals: election of ten directors, ratification of Ernst & Young LLP as independent auditor, non-binding advisory vote on executive compensation, and approval of the Third Amendment to the 2016 Omnibus Compensation Plan. All four proposals passed by majority vote.
View raw filing on EDGAR →The disclosure announces Board approval of a $300 million increase to the Company's share repurchase program, bringing total authorization to $600 million. While share repurchase programs are capital allocation decisions that affect shareholder value and are material to investors, this event does not fit cleanly into the more specific taxonomy categories (it is not an earnings release, executive change, M&A activity, impairment, or other defined event type). The materiality stems from the significant capital commitment and signaling effect on management's confidence in the stock valuation.
View raw filing on EDGAR →Cycurion entered into an Agreement and Plan of Merger on May 7, 2026, to acquire Halo Privacy, Inc. and havenX, Inc. through subsidiary mergers, with aggregate consideration of $1.0 million cash at closing, $1.5 million in Parent stock, and up to $7.5 million in future earnout, installment, and contingent payments, with expected closing at the end of June 2026.
View raw filing on EDGAR →Blue Owl Technology Income Corp. completed an unregistered sale of 255,168 shares of Class I common stock for approximately $2.51 million as of May 1, 2026, exempt under Section 4(a)(2) and Regulation S.
View raw filing on EDGAR →The filing discloses routine monthly distribution declarations and ongoing offering status updates, along with material portfolio and leverage metrics including 155 portfolio companies, $5.0B par value, 0.82x net leverage, and $1.3B liquidity.
View raw filing on EDGAR →IREN's subsidiary IE US Hardware entered into a $1.6 billion purchase agreement with Dell for GPUs to support the company's previously announced $3.4 billion managed services AI cloud contract. This material acquisition of assets is strategically important to the execution of a major revenue contract and reflects significant capital deployment.
View raw filing on EDGAR →Shareholders voted at the 2026 Annual Meeting on May 19, 2026, electing five directors (Gina D. Boggess, John D. Cox, James W. Kiser, Elizabeth Keene, and Blaine S. White II) and ratifying Yount, Hyde & Barbour, P.C. as independent auditor, with detailed vote tallies disclosed for each nominee and proposal.
View raw filing on EDGAR →D-Wave announced second-year funding for the SQFab project awarded by the U.S. Department of War through NORDTECH, a regional defense technology hub. While this is a government contract award that could be material to investors assessing the company's revenue pipeline and strategic positioning in quantum computing for defense applications, it does not fit neatly into the more specific event categories (not an earnings release, M&A activity, executive change, or financial restatement). The disclosure emphasizes recognition of quantum computing's role in U.S. microelectronics innovation, suggesting competitive and strategic significance.
View raw filing on EDGAR →